Tazemetostat Expanded Access Program for Adults With Solid Tumors

Summary

Patients with a diagnosis listed under "conditions" below are eligible to be considered for the EAP. These conditions must be serious or life-threatening at the time of enrollment and appropriate, comparable, or satisfactory alternative treatments must have been tried without clinical success. Patients with conditions not listed under "conditions" below are not eligible for the tazemetostat EAP.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications